U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Med Shop Total Care, Inc. - 581309 - 10/11/2023
  1. Warning Letters

CLOSEOUT LETTER

Med Shop Total Care, Inc. MARCS-CMS 581309 —

Delivery Method:
VIA Electronic Mail
Product:
Animal & Veterinary
Recipient:
Recipient Name
Jennifer D. Yoakum
Recipient Title
Co-Owner and Pharmacist-In-Charge
Med Shop Total Care, Inc.

479 E. Loop 281
Longview, TX 75605-7939
United States

jyoakum@medshoptotalcare.com
Issuing Office:
Office of Pharmaceutical Quality Operations, Division II

United States

Dear Ms. Yoakum:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letters (Case #581309) dated July 30, 2019, and (Case #628182) dated March 18, 2022. Based on our evaluation, it appears that you have adequately addressed the violations contained in these warning letters.

You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Ronda Loyd-Jones
Director, Compliance Branch
Office of Pharmaceutical Quality Operations,
Division II

Back to Top